Texas Instruments Inc

For the transition period from ___________ to ___________ Commission File Number 001-03761

TEXAS INSTRUMENTS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)

Delaware 75-0289970 (State of Incorporation) (I.R.S. Employer Identification No.) 12500 TI Boulevard , Dallas , Texas 75243 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code 214 - 479-3773

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ 913,770,316 Number of shares of Registrant's common stock outstanding as of October 14, 2026

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

PART I - FINANCIAL INFORMATION ITEM 1. Financial statements

For Three Months Ended For Nine Months Ended Consolidated Statements of Income September 30, September 30, (In millions, except per-share amounts) 2026 2025 2026 2025 Revenue $ 6,055 $ 4,742 $ 16,343 $ 13,259 Cost of revenue (COR) 2,168 2,019 6,305 5,648 Gross profit 3,887 2,723 10,038 7,611 Research and development (R&D) 530 518 1,575 1,562 Selling, general and administrative (SG&A) 476 457 1,430 1,414 Acquisition charges 7 - 41 - Restructuring charges/other - 85 - 85 Operating profit 2,874 1,663 6,992 4,550 Other income (expense), net (OI&E) 72 62 188 190 Interest and debt expense 141 141 423 402 Income before income taxes 2,805 1,584 6,757 4,338 Provision for income taxes 380 220 807 500 Net income $ 2,425 $ 1,364 $ 5,950 $ 3,838 Earnings per common share (EPS): Basic $ 2.64 $ 1.49 $ 6.49 $ 4.20 Diluted $ 2.62 $ 1.48 $ 6.44 $ 4.18 Average shares outstanding: Basic 914 909 912 909 Diluted 921 914 918 914 A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS is calculated using the following: Net income $ 2,425 $ 1,364 $ 5,950 $ 3,838 Income allocated to RSUs ( 14 ) ( 8 ) ( 34 ) ( 21 ) Income allocated to common stock for diluted EPS $ 2,411 $ 1,356 $ 5,916 $ 3,817 See accompanying notes.

For Three Months Ended For Nine Months Ended Consolidated Statements of Comprehensive Income September 30, September 30, (In millions) 2026 2025 2026 2025 Net income $ 2,425 $ 1,364 $ 5,950 $ 3,838 Changes in other comprehensive income (loss), net of tax Net actuarial losses of defined benefit plans: Adjustments 1 1 3 ( 19 ) Recognized within net income 1 5 2 11 Prior service cost (credit) of defined benefit plans: Adjustments 1 - 2 - Recognized within net income 1 - 2 - Available-for-sale investments and other: Adjustments ( 6 ) 1 ( 9 ) ( 1 ) Other comprehensive income (loss) ( 2 ) 7 - ( 9 ) Total comprehensive income $ 2,423 $ 1,371 $ 5,950 $ 3,829 See accompanying notes.

September 30, December 31, Consolidated Balance Sheets 2026 2025 (In millions, except par value) Assets Current assets: Cash and cash equivalents $ 4,211 $ 3,225 Short-term investments 3,931 1,656 Accounts receivable, net of allowances of ($ 27 ) and ($ 22 ) 2,620 1,963 Raw materials 497 465 Work in process 2,482 2,372 Finished goods 1,693 1,967 Inventories 4,672 4,804 Prepaid expenses and other current assets 1,446 2,102 Total current assets 16,880 13,750 Property, plant and equipment at cost 18,072 17,682 Accumulated depreciation ( 6,239 ) ( 5,362 ) Property, plant and equipment 11,833 12,320 Goodwill 4,330 4,330 Deferred tax assets 1,054 967 Capitalized software licenses 301 238 Overfunded retirement plans 320 324 Other long-term assets 2,121 2,656 Total assets $ 36,839 $ 34,585 Liabilities and stockholders' equity Current liabilities: Current portion of long-term debt $ 650 $ 500 Accounts payable 837 756 Accrued compensation 675 829 Income taxes payable 60 67 Accrued expenses and other liabilities 795 1,007 Total current liabilities 3,017 3,159 Long-term debt 12,905 13,548 Underfunded retirement plans 118 124 Deferred tax liabilities 62 66 Other long-term liabilities 1,552 1,415 Total liabilities 17,654 18,312 Stockholders' equity: Preferred stock, $ 25 par value. Shares authorized - 10 ; none issued - - Common stock, $ 1 par value. Shares authorized - 2,400 ; shares issued - 1,741 1,741 1,741 Paid-in capital 5,202 4,511 Retained earnings 54,282 52,236 Treasury common stock at cost Shares: September 30, 2026 - 827 ; December 31, 2025 - 834 ( 41,955 ) ( 42,130 ) Accumulated other comprehensive income (loss), net of taxes (AOCI) ( 85 ) ( 85 ) Total stockholders' equity 19,185 16,273 Total liabilities and stockholders' equity $ 36,839 $ 34,585 See accompanying notes.

For Nine Months Ended Consolidated Statements of Cash Flows September 30, (In millions) 2026 2025 Cash flows from operating activities Net income $ 5,950 $ 3,838 Adjustments to net income: Depreciation 1,643 1,381 Amortization of capitalized software 63 61 Stock compensation 331 338 Gains on sales of assets ( 13 ) - Deferred taxes ( 92 ) ( 134 ) Increase (decrease) from changes in: Accounts receivable ( 657 ) ( 343 ) Inventories 132 ( 302 ) Prepaid expenses and other current assets 9 2 Accounts payable and accrued expenses 51 57 Accrued compensation ( 170 ) ( 134 ) Income taxes payable 435 168 Changes in funded status of retirement plans 1 ( 14 ) Other ( 41 ) ( 19 ) Cash flows from operating activities 7,642 4,899 Cash flows from investing activities Capital expenditures ( 1,653 ) ( 3,625 ) Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives 1,104 335 Proceeds from asset sales 37 1 Purchases of short-term investments ( 5,311 ) ( 2,644 ) Proceeds from short-term investments 3,078 5,198 Other 9 ( 28 ) Cash flows from investing activities ( 2,736 ) ( 763 ) Cash flows from financing activities Proceeds from issuance of long-term debt - 1,199 Repayment of debt ( 500 ) ( 750 ) Dividends paid ( 3,884 ) ( 3,709 ) Stock repurchases ( 233 ) ( 1,074 ) Proceeds from common stock transactions 770 358 Other ( 73 ) ( 49 ) Cash flows from financing activities ( 3,920 ) ( 4,025 ) Net change in cash and cash equivalents 986 111 Cash and cash equivalents at beginning of period 3,225 3,200 Cash and cash equivalents at end of period $ 4,211 $ 3,311 Supplemental cash flow information Investment tax credit (ITC) used to reduce income taxes payable $ 380 $ 246 Proceeds from CHIPS Act incentives 1,104 335 Total cash benefit related to the CHIPS Act $ 1,484 $ 581 See accompanying notes.

Notes to financial statements 1. Description of business, including segment and geographic area information We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. We have two reportable segments, Analog and Embedded Processing, each of which represents groups of products that have similar design and development requirements, product characteristics and manufacturing processes. Our segments reflect how our chief operating decision maker (CODM), which is our chief executive officer, allocates resources and measures results. • Analog semiconductors change real-world signals, such as sound, temperature, pressure or light, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing, discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog segment consists of two major product lines: Power and Signal Chain. • Embedded Processing products are the digital "brains" of many types of electronic equipment. They are designed to handle specific tasks and can be optimized for various combinations of performance, power and cost, depending on the application. We report the results of our remaining business activities in Other. Other includes DLP ® products and calculators, which are operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. In Other, we also include items that are not used in evaluating the results of or in allocating resources to our segments. Examples of these items include acquisition, integration and restructuring charges, and certain corporate-level items, such as litigation expenses, environmental costs, insurance settlements, and gains and losses from other activities, including asset dispositions. We allocate the remainder of our expenses associated with corporate activities to our operating segments based on specific methodologies, such as percentage of operating expenses or headcount. Costs incurred by our centralized manufacturing and support organizations, including depreciation, are charged to the operating segments, including those in Other, on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments' results and, therefore, is not provided. With the exception of goodwill, we do not identify or allocate assets by operating segment, nor does the CODM evaluate operating segments using discrete asset information. We have no material intersegment revenue. The accounting policies of the segments are consistent with those described in the significant accounting policies and practices. Segment information For Three Months Ended September 30, 2026 2025 Analog Embedded Processing Other Total Analog Embedded Processing Other Total Revenue $ 4,911 $ 858 $ 286 $ 6,055 $ 3,729 $ 709 $ 304 $ 4,742 Cost of revenue 1,697 390 81 2,168 1,543 373 103 2,019 Gross profit 3,214 468 205 3,887 2,186 336 201 2,723 R&D 377 134 19 530 371 127 20 518 SG&A 332 107 37 476 329 101 27 457 Acquisition charges - - 7 7 - - - - Restructuring charges/other - - - - - - 85 85 Operating profit $ 2,505 $ 227 $ 142 $ 2,874 $ 1,486 $ 108 $ 69 $ 1,663

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Geographic area information Our estimate for revenue based on the geographic location of our end customers' headquarters, which represents where critical decisions are made, is as follows: For Three Months Ended For Nine Months Ended September 30, September 30, 2026 2025 2026 2025 Revenue: United States $ 2,348 39 % $ 1,859 39 % $ 6,275 38 % $ 5,084 38 % China 1,392 23 1,019 21 3,639 22 2,830 21 Rest of Asia 635 10 505 11 1,796 11 1,430 11 Europe, Middle East and Africa (a) 1,207 20 972 20 3,352 21 2,799 21 Japan 369 6 313 7 988 6 883 7 Rest of world 104 2 74 2 293 2 233 2 Total revenue $ 6,055 100 % $ 4,742 100 % $ 16,343 100 % $ 13,259 100 %

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Significant accounting policies and practices Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing nonforfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock. Computation and reconciliation of earnings per common share are as follows: For Three Months Ended September 30, 2026 2025 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 2,425 $ 1,364 Income allocated to RSUs ( 14 ) ( 8 ) Income allocated to common stock $ 2,411 914 $ 2.64 $ 1,356 909 $ 1.49 Dilutive effect of stock compensation plans 7 5 Diluted EPS: Net income $ 2,425 $ 1,364 Income allocated to RSUs ( 14 ) ( 8 ) Income allocated to common stock $ 2,411 921 $ 2.62 $ 1,356 914 $ 1.48 For Nine Months Ended September 30, 2026 2025 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 5,950 $ 3,838 Income allocated to RSUs ( 34 ) ( 21 ) Income allocated to common stock $ 5,916 912 $ 6.49 $ 3,817 909 $ 4.20 Dilutive effect of stock compensation plans 6 5 Diluted EPS: Net income $ 5,950 $ 3,838 Income allocated to RSUs ( 34 ) ( 21 ) Income allocated to common stock $ 5,916 918 $ 6.44 $ 3,817 914 $ 4.18

Potentially dilutive securities excluded from the computation of diluted earnings per common share during the third quarter of 2026 were not material. Potentially dilutive securities representing 4 million shares of common stock that were outstanding during the third quarter of 2025, and 2 million and 10 million shares outstanding during the first nine months of 2026 and 2025, respectively, were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-dilutive. Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. 8

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the fair value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions were not material. We do not use derivatives for speculative or trading purposes. Fair values of financial instruments The fair values of our derivative financial instruments were not material as of September 30, 2026. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of September 30, 2026, the carrying value of long-term debt, including the current portion, was $ 13.56 billion, and the estimated fair value was $ 11.86 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs. Changes in accounting standards - standards not yet adopted We are currently evaluating the potential impact of the following Accounting Standards Updates (ASU) on our financial statements and related disclosures. We plan to adopt these ASUs as of their effective dates. ASU Description Effective for Period Ending ASU No. 2024-03 Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses December 31, 2027 ASU No. 2025-06 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software March 31, 2028 ASU No. 2025-10 Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities March 31, 2029

3. Income taxes Provision for income taxes is based on the following: For Three Months Ended For Nine Months Ended September 30, September 30, 2026 2025 2026 2025 Taxes calculated using the estimated annual effective tax rate $ 390 $ 249 $ 928 $ 614 Discrete tax items ( 10 ) ( 29 ) ( 121 ) ( 114 ) Provision for income taxes $ 380 $ 220 $ 807 $ 500 Effective tax rate 14 % 14 % 12 % 12 %

The effective tax rate differs from the 21 % U.S. statutory corporate tax rate due to the effect of U.S. tax benefits. 9

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

4. Valuation of debt and equity investments and certain liabilities Investments measured at fair value Money market funds, debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. We classify all debt investments as available-for-sale. Unrealized gains and losses are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and nonmarketable investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other nonmarketable securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee's financial results. Nonmarketable securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on nonmarketable investments are recognized in OI&E. Details of our investments are as follows: September 30, 2026 December 31, 2025 Cash and Cash Equivalents Short-Term Investments Other Long-Term Assets Cash and Cash Equivalents Short-Term Investments Other Long-Term Assets Measured at fair value: Money market funds $ 1,381 $ - $ - $ 844 $ - $ - Corporate obligations 597 960 - 517 522 - U.S. government and agency securities 1,539 2,476 - 1,296 1,035 - Non-U.S. government and agency securities 299 495 - 184 99 - Mutual funds - - 11 - - 11 Total 3,816 3,931 11 2,841 1,656 11 Other investments - - 4 - - 5 Cash on hand 395 - - 384 - - Total $ 4,211 $ 3,931 $ 15 $ 3,225 $ 1,656 $ 16

As of September 30, 2026, and December 31, 2025, unrealized gains and losses associated with our debt investments were not material. We did no t recognize any credit losses related to debt investments for the first nine months of 2026 and 2025. The following table presents the aggregate maturities of our debt investments as of September 30, 2026: Fair Value One year or less $ 5,688 One to two years 678

Proceeds from sales, redemptions and maturities of short-term debt investments were $ 1.40 billion and $ 1.26 billion for the third quarters of 2026 and 2025, respectively, and $ 3.08 billion and $ 5.20 billion for the first nine months of 2026 and 2025, respectively. Gross realized gains and losses from these sales were not material. 10

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the inputs used to estimate fair-value measurements. • Level 1 - Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the measurement date. • Level 2 - Uses inputs other than Level 1 that are either directly or indirectly observable as of the measurement date through correlation with market data. Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active and models or other pricing methodologies that do not require significant judgment. We utilize a third-party data service to provide Level 2 valuations, and we verify these valuations for reasonableness. • Level 3 - Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. As of September 30, 2026, and December 31, 2025, we had no Level 3 assets or liabilities. The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. September 30, 2026 December 31, 2025 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 1,381 $ - $ 1,381 $ 844 $ - $ 844 Corporate obligations - 1,557 1,557 - 1,039 1,039 U.S. government and agency securities 3,524 491 4,015 1,932 399 2,331 Non-U.S. government and agency securities - 794 794 - 283 283 Mutual funds 11 - 11 11 - 11 Total assets $ 4,916 $ 2,842 $ 7,758 $ 2,787 $ 1,721 $ 4,508 Liabilities: Deferred compensation $ 503 $ - $ 503 $ 492 $ - $ 492 Total liabilities $ 503 $ - $ 503 $ 492 $ - $ 492

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

5. Postretirement benefit plans Expenses related to defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Three Months Ended September 30, 2026 2025 2026 2025 2026 2025 Service cost $ 2 $ 1 $ 1 $ - $ 3 $ 4 Interest cost 6 6 3 3 16 16 Expected return on plan assets ( 5 ) ( 3 ) ( 3 ) ( 2 ) ( 17 ) ( 20 ) Recognized net actuarial losses (gains) 1 1 ( 1 ) - ( 1 ) 1 Amortization of prior service cost (credit) - - - - 1 - Net periodic benefit costs (credits) 4 5 - 1 2 1 Settlement losses (gains) 2 4 - - - - Total, including other postretirement losses (gains) $ 6 $ 9 $ - $ 1 $ 2 $ 1 U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Nine Months Ended September 30, 2026 2025 2026 2025 2026 2025 Service cost $ 5 $ 5 $ 1 $ 1 $ 11 $ 11 Interest cost 17 19 9 9 49 45 Expected return on plan assets ( 15 ) ( 13 ) ( 8 ) ( 8 ) ( 56 ) ( 55 ) Recognized net actuarial losses (gains) 3 5 ( 1 ) ( 1 ) ( 3 ) 3 Amortization of prior service cost (credit) - - - - 3 - Net periodic benefit costs (credits) 10 16 1 1 4 4 Settlement losses (gains) 4 7 - - ( 1 ) - Total, including other postretirement losses (gains) $ 14 $ 23 $ 1 $ 1 $ 3 $ 4

6. Debt and lines of credit Short-term borrowings We maintain a line of credit to provide additional liquidity through bank loans and, if necessary, to support commercial paper borrowings. As of September 30, 2026, the aforementioned line of credit was a variable-rate, revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $ 1 billion until March 2027. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable Term Secured Overnight Financing Rate (Term SOFR). As of September 30, 2026, our credit facility was undrawn, and we had no commercial paper outstanding. In June 2026, we entered into a 364-day delayed draw term loan credit facility for borrowings up to $ 5 billion to support the Silicon Labs acquisition consideration and related transaction expenses. The availability of funding is conditioned on the consummation of the planned acquisition of Silicon Labs. As of September 30, 2026, there were no outstanding borrowings on the delayed draw term loan credit facility. Long-term debt In September 2026, we retired $ 500 million of maturing debt. 12

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Interest and debt expense was $ 141 million for the third quarters of both 2026 and 2025, and $ 423 million and $ 402 million for the first nine months of 2026 and 2025, respectively. This is inclusive of amortized discounts, premiums and issuance and other related costs. Capitalized interest was $ 3 million for the third quarters of both 2026 and 2025, and $ 9 million for the first nine months of both 2026 and 2025. 13

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

7. Stockholders' equity Changes in equity are as follows: Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2025 $ 1,741 $ 4,511 $ 52,236 $ ( 42,130 ) $ ( 85 ) 2026 Net income - - 1,545 - - Dividends declared and paid ($ 1.42 per share) - - ( 1,291 ) - - Common stock issued for stock-based awards - 105 - 204 - Stock repurchases - - - ( 158 ) - Stock compensation - 109 - - - Other comprehensive income (loss), net of taxes - - - - 1 Dividend equivalents on RSUs - - ( 8 ) - - Other - ( 3 ) 1 - - Balance, March 31, 2026 1,741 4,722 52,483 ( 42,084 ) ( 84 ) Net income - - 1,980 - - Dividends declared and paid ($ 1.42 per share) - - ( 1,295 ) - - Common stock issued for stock-based awards - 279 - 166 - Stock repurchases - - - ( 23 ) - Stock compensation - 127 - - - Other comprehensive income (loss), net of taxes - - - - 1 Dividend equivalents on RSUs - - ( 7 ) - - Other - 1 - - - Balance, June 30, 2026 1,741 5,129 53,161 ( 41,941 ) ( 83 ) Net income - - 2,425 - - Dividends declared and paid ($ 1.42 per share) - - ( 1,298 ) - - Common stock issued for stock-based awards - ( 20 ) - 36 - Stock repurchases - - - ( 50 ) - Stock compensation - 95 - - - Other comprehensive income (loss), net of taxes - - - - ( 2 ) Dividend equivalents on RSUs - - ( 6 ) - - Other - ( 2 ) - - - Balance, September 30, 2026 $ 1,741 $ 5,202 $ 54,282 $ ( 41,955 ) $ ( 85 )

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2024 $ 1,741 $ 3,935 $ 52,262 $ ( 40,895 ) $ ( 140 ) 2025 Net income - - 1,179 - - Dividends declared and paid ($ 1.36 per share) - - ( 1,238 ) - - Common stock issued for stock-based awards - 8 - 110 - Stock repurchases - - - ( 657 ) - Stock compensation - 116 - - - Other comprehensive income (loss), net of taxes - - - - ( 7 ) Dividend equivalents on RSUs - - ( 7 ) - - Other - ( 1 ) - - - Balance, March 31, 2025 1,741 4,058 52,196 ( 41,442 ) ( 147 ) Net income - - 1,295 - - Dividends declared and paid ($ 1.36 per share) - - ( 1,235 ) - - Common stock issued for stock-based awards - 59 - 56 - Stock repurchases - - - ( 290 ) - Stock compensation - 129 - - - Other comprehensive income (loss), net of taxes - - - - ( 9 ) Dividend equivalents on RSUs - - ( 7 ) - - Other - ( 1 ) - - - Balance, June 30, 2025 1,741 4,245 52,249 ( 41,676 ) ( 156 ) Net income - - 1,364 - - Dividends declared and paid ($ 1.36 per share) - - ( 1,236 ) - - Common stock issued for stock-based awards - 72 - 53 - Stock repurchases - - - ( 121 ) - Stock compensation - 93 - - - Other comprehensive income (loss), net of taxes - - - - 7 Dividend equivalents on RSUs - - ( 7 ) - - Other - - ( 1 ) - - Balance, September 30, 2025 $ 1,741 $ 4,410 $ 52,369 $ ( 41,744 ) $ ( 149 )

8. Contingencies Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. 15

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Warranty costs/product liabilities Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our consolidated financial statements. We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. General We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our consolidated financial statements. 9. Supplemental financial information Acquisition of Silicon Labs As announced on February 4, 2026, we have entered into a definitive agreement to acquire Silicon Labs for $ 231.00 per share in an all-cash transaction, representing a total enterprise value of approximately $ 7.5 billion. Under the terms of the agreement, Silicon Labs stockholders will receive $ 231.00 in cash for each share of Silicon Labs common stock they hold at the time of closing, which is expected in the first half of 2027, subject to receipt of regulatory approvals and other customary closing conditions. We expect to fund the transaction with a combination of cash on hand and debt financing. During the third quarter and first nine months of 2026, we incurred $ 7 million and $ 41 million of acquisition charges, respectively. Prepaid expenses and other current assets September 30, December 31, 2026 2025 CHIPS Act incentives $ 1,100 $ 1,709 Other 346 393 Total $ 1,446 $ 2,102

Other long-term assets September 30, December 31, 2026 2025 CHIPS Act incentives $ 1,036 $ 1,639 Other 1,085 1,017 Total $ 2,121 $ 2,656

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES